The Limited Times

Now you can see non-English news...

Kexing Vaccine | A 63-year-old pharmacist who died after vaccination: long-term patients need to control their condition before vaccination

2021-03-03T01:07:21.225Z

The first death case occurred in Hong Kong after being vaccinated with Kexing vaccine. A 63-year-old man suffering from high blood pressure, hyperlipidemia and diabetes received Kexing vaccine last Friday (26th). He had difficulty breathing two days later and went to Queen Elizabeth Hospital on his own.



Social News

Written by: Li Enci

2021-03-03 08:56

Last update date: 2021-03-03 08:56

The first death case occurred in Hong Kong after being vaccinated with Kexing vaccine.

A 63-year-old man suffering from high blood pressure, hyperlipidemia and diabetes was vaccinated with Kexing vaccine last Friday (26th). Two days later, he had difficulty breathing and went to the emergency department of Queen Elizabeth Hospital for medical treatment. He died within less than 5 hours.

Respiratory system specialist Liang Zichao said on a TV program in Hong Kong and Taiwan this morning (3rd) that the patient had no allergies or side effects within 48 hours after vaccination, such as rheumatism, mouth swelling, etc. It does not rule out that the patient has other problems. The incident and the vaccine The probability of direct relationship is quite low.

Cui Junming, president of the Hong Kong Institute of Hospital Pharmacists, said that patients with chronic diseases need to be controlled before they can get vaccinated, and they are advised to consult their family or specialist doctors.

Respiratory specialist Liang Zichao said that the patient's information was fragmentary, but he had no allergic reactions or side effects within 48 hours after vaccination, such as wind disease and mouth swelling, but suddenly had difficulty breathing two days after vaccination.

He believes that the incident is not like a vaccine reaction, and the probability of a direct relationship with the vaccine is quite low.

He said that the inactivated vaccine technology has been used for decades, and the impact should only be local, such as swelling and pain of the needle and stimulating the immune system. Other than that, it has no drug properties and should not constitute this event.

He speculated that the patient may be suffering from bronchitis or chronic obstructive pulmonary disease, but as a matter of principle, his condition should not deteriorate so quickly. It is not ruled out that the patient has other problems, and the real cause of death needs to be investigated.

Liang also said that there have been cases of passing away after vaccination in different places from time to time, and none of them is directly related to the vaccine for the time being.

He urged the public not to worry too much at this stage, emphasizing that chronically ill patients are a high-risk group. If the condition is stable, vaccination is safe.

▼Full list of 29 vaccination centers on Hong Kong Island, Kowloon, New Territories and Outlying Islands▼

Cui Junming, president of the Hong Kong Society of Hospital Pharmacists.

(Profile picture)

Cui Junming, president of the Hong Kong Institute of Hospital Pharmacists, said that patients with chronic diseases need to control their condition before they can be vaccinated.

Diabetes, hypertension, and other patients are at higher risk. If the condition is not controlled, for example, the fasting blood glucose level is greater than 6.5%, etc., it is not suitable for vaccination, so as not to affect the deterioration of the condition.

He pointed out that patients may not know whether their condition is stable and suggest that they consult their family or specialist doctors before making an appointment for vaccination.

He emphasized that chronically ill patients and the elderly belong to the high-risk group of new coronary pneumonia, and single cases should not stop vaccination.

▼See the details of the scheduled vaccination and side effects of Kexing and BioNTech in the 3 pictures▼

Kexing Vaccine | Department of Health of the 63-year-old man who died after vaccination: the causality has not been established

New Coronary Pneumonia·Latest|Fobitai Vaccines Now Accepts Appointments for Kexing Vaccinations

Japanese woman in her 60s died after being vaccinated by Pfizer, government investigating whether it is related to the vaccine

Kexing Vaccine | 63-year-old chronically ill Weng was vaccinated last Friday and died of acute dyspnea on Sunday

Vaccinations | Island East 3 Hospital from Wednesday for the medical and nursing vaccination department to choose Fubitai must come to the center

Fubitel Vaccine will be available for priority group vaccination center vaccination program for the first time from next Wednesday

01News

New crown pneumonia new crown vaccine China Kexing

Source: hk1

All news articles on 2021-03-03

Similar news:

You may like

Trends 24h

News/Politics 2021-04-13T18:44:04.823Z

Latest

© Communities 2019 - Privacy